Talks will include 1) OCT biomarkers in DMO - what adds value in clinical-decision making? - Christiana Dinah, Consultant Ophthalmologist and medical retina specialist, London - 2) Debate: When should you switch treatment in DMO? versus late - Deepali Varma, Consultant Ophthalmologist and medical retina specialist, Sunderland & Phil Burgess, Consultant Ophthalmologist and medical retina specialist, Liverpool
